Medical devices reimbursement is a payment private insurer pays to healthcare providers for costs the provider incurred while using medical devices. Usually, health insurer or government payers cover the patients' healthcare expenses inclusive of medical device use. It is important because it ensures that patients have access to the medical devices they need. 

Market Dynamics:

Increasing prevalence of chronic diseases, growing geriatric (aging) population, increasing cost of healthcare, and supportive government initiatives/programs are major factors expected to augment the growth of the global medical devices reimbursement market.

For instance, in November 2022, RQM+ announced the launch of its reimbursement division. RQM+ reimbursement services range from initial reimbursement strategy development to post-approval market access support. RQM+ now provides comprehensive reimbursement services in addition to regulatory, quality, clinical, and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics.

Key features of the study:

• This report provides in-depth analysis of the global medical devices reimbursement market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global medical devices reimbursement market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include BNP Paribas, CVS Health, Aviva, Allianz, Humana, Cigna, Aetna, Wellcare Health Plans Inc., UnitedHealth Group Inc., and Nippon Life Insurance Company, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global medical devices reimbursement market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical devices reimbursement market.

Detailed Segmentation:

• Global Medical Devices Reimbursement Market, By Payers:
  • Public
  • Private
• Global Medical Devices Reimbursement Market, By Healthcare Setting:
  • Hospitals
  • Outpatient Facilities
  • Others
• Global Medical Devices Reimbursement Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • BNP Paribas
  • CVS Health
  • Aviva
  • Allianz
  • Humana
  • Cigna
  • Aetna
  • Wellcare Health Plans Inc.
  • UnitedHealth Group Inc.,
  • Nippon Life Insurance Company